LSL Pharma Group (TSXV:LSL) ROE % Adjusted to Book Value : -3.59% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group ROE % Adjusted to Book Value?

LSL Pharma Group's ROE % for the quarter that ended in Mar. 2024 was -9.61%. LSL Pharma Group's PB Ratio for the quarter that ended in Mar. 2024 was 2.68. LSL Pharma Group's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -3.59%.

LSL Pharma Group ROE % Adjusted to Book Value Historical Data

The historical data trend for LSL Pharma Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group ROE % Adjusted to Book Value Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-26.30

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-35.93	-33.32	-7.38	-4.48	-3.59

Competitive Comparison of LSL Pharma Group's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's ROE % Adjusted to Book Value falls into.

LSL Pharma Group ROE % Adjusted to Book Value Calculation

LSL Pharma Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-121.50%	/	4.62
	=	-26.30%

LSL Pharma Group's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-9.61%	/	2.68
	=	-3.59%

LSL Pharma Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines